Trofinetide
Trofinetide19About
What does Trofinetide do?
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for central nervous system (CNS) disorders. Their key product, DAYBUE® (trofinetide), is the first and only FDA-approved drug for the treatment of Rett syndrome in adult and pediatric patients two years of age and older. Acadia has expanded its global reach for trofinetide through licensing agreements and continues to advance its pipeline for other neurological conditions.
What is Trofinetide's Effective Domain Rating?
StartupHub's Effective Domain Rating for Trofinetide is 89 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 70, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Trofinetide trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Trofinetide is 92 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
What is Trofinetide's revenue?
StartupHub estimates Trofinetide's annual revenue at $98.9M (range $60.0M to $337.4M, 68% confidence), based on comparable companies in the sector.
When was Trofinetide founded?
Trofinetide was founded in 2026.
What industry does Trofinetide operate in?
Trofinetide operates in Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech, Neuroscience.
How many employees does Trofinetide have?
Trofinetide has approximately 1032 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
AI-powered platform for peptide design and discovery.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.